Phase I pharmacokinetic, food effect, and pharmacogenetic study of oral irinotecan given as semisolid matrix capsules in patients with solid tumors (Q33212496)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase I pharmacokinetic, food effect, and pharmacogenetic study of oral irinotecan given as semisolid matrix capsules in patients with solid tumors
scientific article

    Statements

    Phase I pharmacokinetic, food effect, and pharmacogenetic study of oral irinotecan given as semisolid matrix capsules in patients with solid tumors (English)
    Otto Soepenberg
    Herlinde Dumez
    Floris A de Jong
    Maja J A de Jonge
    José Thomas
    Ferry A L M Eskens
    Ron H N van Schaik
    Johan Selleslach
    Judith Ter Steeg
    Patricia Lefebvre
    Sylvie Assadourian
    Ger-Jan Sanderink
    Allan T van Oosterom
    1 February 2005
    1504-1511

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit